Transformation of prostate adenocarcinoma to squamous. Case report and literature review

Authors

  • Héctor Macías de Hoyos Instituto de Seguridad Social del Estado de México y Municipios, Centro Médico Arturo Montiel Rojas, Estado de México, México.
  • Eddy Gabriel Muñoz-Lumbreras Instituto de Seguridad Social del Estado de México y Municipios, Centro Oncológico Estatal, Estado de México, México.
  • José Juan Guadalupe Arias-Patiño Instituto de Seguridad Social del Estado de México y Municipios, Centro Oncológico Estatal, Estado de México, México.
  • Ramiro García-Ortiz Instituto de Seguridad Social del Estado de México y Municipios, Centro Oncológico Estatal, Estado de México, México.
  • Marco Antonio Aragón-Castro Instituto de Seguridad Social del Estado de México y Municipios, Centro Oncológico Estatal, Estado de México, México.
  • Guillermo Enrique Ruvalcaba-Oceguera Instituto de Seguridad Social del Estado de México y Municipios, Centro Médico Arturo Montiel Rojas, Estado de México, México.
  • Rubén Gutiérrez-Rosales Instituto de Seguridad Social del Estado de México y Municipios, Centro Médico Arturo Montiel Rojas, Estado de México, México.
  • Erick Santana-Maya Instituto de Seguridad Social del Estado de México y Municipios, Centro Médico Arturo Montiel Rojas, Estado de México, México.
  • Rigoberto Dolores-Velázquez Instituto de Seguridad Social del Estado de México y Municipios, Centro Oncológico Estatal, Estado de México, México.
  • César Eduardo Rosales-Velázquez Instituto de Seguridad Social del Estado de México y Municipios, Centro Médico Arturo Montiel Rojas, Estado de México, México.

DOI:

https://doi.org/10.48193/revistamexicanadeurologa.v82i3.858

Keywords:

Prostate squamous cell carcinoma, prostate adenocarcinoma

Abstract

Clinical case description: A 65-year-old male who came to the emergency room due to non-clot-forming holomictional hematuria. Diagnostic approach is started, identifying in the medical history the diagnosis of prostate adenocarcinoma stage 4 without radiotherapy. Due to the patient's symptoms, surgical treatment is performed, where squamous carcinoma of the prostate is reported. Therefore, the evolution and treatment of the patient is monitored

Relevance: It is known that patients with squamous cell carcinoma of the prostate have a short survival from the moment of diagnosis. There are few case reports on this entity and its treatment of choice.

Clinical implications: There is not a enough data to determine the management of this type of patients. The reported incidence is minimal and there is no specific treatment for these patients.

Conclusion: Squamous cell carcinoma of the prostate is a rare entity. There is little information on the possible management and prognosis in this type of cancer is adverse. Therefore, it is of the utmost importance to open new areas of research on this type of cancer.

References

Sarma DP, Weilbaecher TG, Moon TD. Squamous cell carcinoma of prostate. Urology. 1991;37(3):260–2. doi: https://doi.org/10.1016/0090-4295(91)80299-M

Moskovitz B, Munichor M, Bolkier M, Livne PM. Squamous Cell Carcinoma of the Prostate. UIN. 1993;51(3):181–3. doi: https://doi.org/10.1159/000282540

Lee J. Transformation of adenocarcinoma of prostate to squamous cell carcinoma following hormonal treatment: A case report and review of the literature. Radiology Case Reports. 2019;14(4):483–9. doi: https://doi.org/10.1016/j.radcr.2019.01.015

Braslis KG, David RC, Nelson E, Civantos F, Soloway MS. Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide. Urology. 1995;45(2):329–31. doi: https://doi.org/10.1016/0090-4295(95)80028-X

Al–Qassim Z, Mohammed A, Payne D, Stocks PJ, Khan Z. Squamous cell carcinoma of the prostate following treatment with an LHRH–agonist: a rare case of transformation of adenocarcinoma of the prostate. Cent European J Urol. 2014;67(1):26–8. doi: https://doi.org/10.5173/ceju.2014.01.art5

Matsugasumi T, Nakanishi H, Yokota T, Shiraishi T, Ukimura O. Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma. IJU Case Reports. 2020;3(4):121–4. doi: https://doi.org/10.1002/iju5.12161

Munoz F, Franco P, Ciammella P, Clerico M, Giudici M, Filippi AR, et al. Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation. Radiation Oncology. 2007;2(1):15. doi: https://doi.org/10.1186/1748-717X-2-15

Biswas T, Podder T, Lepera PA, Walker P. Primary squamous cell carcinoma of the prostate: a case report of a rare clinical entity. Future Science OA. 2015;1(3). doi: https://doi.org/10.4155/fso.15.16

Wernert N, Goebbels R, Bonkhoff H, Dhom G. Squamous cell carcinoma of the prostate. Histopathology. 1990;17(4):339–44. doi: https://doi.org/10.1111/j.1365-2559.1990.tb00738.x

Okada E, Kamizaki H. Primary squamous cell carcinoma of the prostate. Int J Urol. 2000;7(9):347–50. doi: https://doi.org/10.1046/j.1442-2042.2000.00204.x.

He X, Yang K, Chen G, Zheng J. Squamous cell carcinoma of the prostate with lower urinary tract symptoms: A case report. Urol Case Rep. 2021;39:101796. doi: https://doi.org/10.1016/j.eucr.2021.101796

Hutten RJ, Weil CR, Tward JD, Lloyd S, Johnson SB. Patterns of Care and Treatment Outcomes in Locoregional Squamous Cell Carcinoma of the Prostate. Eur Urol Open Sci. 2021;23:30–3. doi: https://doi.org/10.1016/j.euros.2020.11.008.

Little NA, Wiener JS, Walther PJ, Paulson DF, Anderson EE. Squamous cell carcinoma of the prostate: 2 cases of a rare malignancy and review of the literature. J Urol. 1993;149(1):137–9. doi: https://doi.org/10.1016/s0022-5347(17)36024-x

Atagi K, Fukuhara H, Ishiguro M, Osakabe H, Satoshi F, Tamura K, et al. Successful treatment with DCF chemotherapy and radiotherapy for primary squamous cell carcinoma of the prostate. IJU Case Rep. 2021;4(6):421–4. doi: https://doi.org/10.1002/iju5.12365

Onoda M, Sugimoto R, Uesugi N, Takayama M, Shiomi E, Kato R, et al. Novel combination chemotherapy with radiotherapy for prostate squamous cell carcinoma. Int Cancer Conf J. 2017;6(1):25–8. doi: https://doi.org/10.1007/s13691-016-0266-6

Downloads

Published

2022-06-30

Issue

Vol. 82 No. 3 (2022): May-June

Section

Clinical cases